MILFORD, Mass., May 2, 2011 /PRNewswire/ — SeraCare Life
Sciences announced today that the National Heart, Lung, and Blood
Institute (NHLBI) of the National Institutes of Health has awarded
a new contract to SeraCare, replacing the current contract which
expired on April 30, 2011. Under this contract, SeraCare, at the
direction of the NHLBI, will advise on proper collection,
processing and storage for biorepository collections. SeraCare will
also continue to acquire, store and distribute biospecimens to the
scientific community for use in research related to
transfusion-transmitted diseases and a variety of other disorders
of the blood and the cardiovascular and respiratory systems. The
contract is valued at $17.6 million over a five-year term, for an
average of $3.5 million per year, if all options are exercised by
the NHLBI.
(Logo:
http://photos.prnewswire.com/prnh/20110324/NE70714LOGO)
“The National Institutes of Health is a long-standing, highly
valued customer of SeraCare’s services business and its commitment
to a continued relationship speaks to SeraCare’s exemplary
leadership in this space,” said Susan Vogt, President and Chief
Executive Officer of SeraCare. “SeraCare’s biorepository is a
best-in-class facility. We store and manage more than 15 million
biological samples for government and commercial customers that are
critical for scientific research, disease control, drug and
diagnostic development and national defense. Our relationship with
the National Heart, Lung, and Blood Institute has been in place for
more than 12 years and we are pleased to continue this important
strategic collaboration.”
This project has been funded in whole with Federal funds from
the National Heart, Lung, and Blood Institute, National Institutes
of Health, Department of Health and Human Services, under Contract
No.HHSN268201100031C.
About SeraCare Life Sciences, Inc.
SeraCare serves the global life sciences industry by providing
vi
‘/>”/>
